Dendritic cell cancer vaccines are a leading area of cancer research. BioPulse believes its new method is a substantial improvement over methods used by other companies. Dendritic cell cancer vaccines use the body's natural defense system to combat cancer. These cells recognise specific chemicals, or antigens, that are produced by disease-causing agents. In a healthy immune system, antigens trigger the production of immune system cells, which leads to the eventual removal of antigens from the body.
Dendritic cells are a specialised type of immune system cells.
Dendritic cells initiate the immune response by processing antigen and presenting it to lymphocytes to stimulate production of more lymphocytes. T-cells are a type of lymphocyte that combat disease by killing antigen bearing cells directly. T-cells eliminate cancer cells and tissue infected by viruses. On a daily basis, the immune system recognises and responds to thousands of different antigens encountered inside the body. This is what keeps an individual healthy.